focus -WSS

focus

author：comprehensive 2025-08-12 09:10:42 - browse：95

The U.S. Department of Labor claims in a new lawsuit that a UnitedHealth Group unit illegally rejected emergency room care and urine drug screen claims for thousands of people.

UMR, Inc., a Wisconsin-based third-party administrator owned by UnitedHealth, manages benefits for more than 2,100 employee health plans. The federal government says the company denied ER visits and urine drug screens for years using a process that didn’t meet federal standards for health plans that employers fund themselves, known as self-insured plans. The standards are part of a law called the Employee Retirement Income Security Act, or ERISA.

“I see it as significant because the Department of Labor is actually looking under the hood at the standards and methods that insurers apply when they decide whether or not to approve or deny a claim,” said Colleen Medill, a professor at the University of Nebraska College of Law and nationally recognized legal scholar on ERISA. “They are looking at their process.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： People with mental disorders often marry others with same

focus

WSS

It's time to get medical device identifiers over the finish line

Lecanemab for Alzheimer's is coming. Is the health system ready?

Hundreds died while taking an arthritis drug, but nobody alerted patients

What to know about OceanGate, the company behind the missing Titanic submersible

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

entertainment

focus

entertainment

The high cost of giving birth even with insurance

Young boy dies in trial for Pfizer Duchenne gene therapy

Supreme Court strikes down use of affirmative action

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Guidelines to prevent youth baseball injuries need more muscle

Elizabeth Holmes on track for early release from her 11

State Dept. review finds Biden bears some blame for Afghanistan failures

Lecanemab for Alzheimer's is coming. Is the health system ready?

explore

Pancreatic cancer is often deadly, but new discoveries are raising hope

Alzheimer's risk factor APOE4 may be a distinct form of the disease

New research casts further doubt on a common procedure used with IVF

Mass General Brigham physicians react to latest merger step

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Oral obesity drug from Viking Therapeutics hits key early target

focus

Wikipedia

focus

hotspot